Alzheimer Disease (AD)

 

Epidemiology and Etiology:

·         Most common cause of dementia in the elderly

·         40% prevalence in 85-90y cohort

·         Rarely symptomatic before 50y

·         Sporadic mostly

·         5-10% familial

·         Trisomy 21

·         Nearly 100% over age 45y

·         APP is on chromosome 21

·         May result in overexpression and subsequent production of

·         is thought to be a critical molecule in the pathogenesis

·         Derived from cleavage of APP by beta- and gamma- secretase

 

Common sites:

·         Earliest (stages I,II):

·         Entorhinal cortex (at uncus) (anterior of hippocampus – squiggly part)

·         Then (stages III, IV):

·         Hippocampal formation

·         Latest (stages V, VI)

·         Neocortex / isocortex (take a section at the occipital pole with striate and peristriate cortex)

·         Sparing of primary motor and sensory cortex

 

Gross features:

·         Cortical atrophy

·         Widening of gyri

·         Most pronounced frontal, temporal, parietal

·         Ventricular enlargement

 

Histologic features:

·         Neuritic (senile) plaques

·         20-200 um diameter

·         Spherical collections of dilated, tortuous, silver-staining neuritic processes

·         Central amyloid core often

·         Surrounded by a clear halo maybe

·         Microglia and reactive astrocytes at the periphery

·         Neurofibrillary tangles

·         Bundles of filaments in the neuron cytoplasm that displace or encircle the nucleus

·         Tau protein is a major component

·         Basophilic fibrillary structures on H&E

·         Silver (Bielchowsky) stain positive

·         Remain after death of neuron

·         Not specific to Alzheimer

·         Braak staging:

·         Stage I,II (transentorhinal):

·         Involvement only of transentorhinal cortex (see above)

·         Stage III, IV (limbic):

·         Severe involvement of transentorhinal cortex

·         Moderate involvement of CA1 of hippocampus

·         None to mild involvement of isocortex

·         Stage V, VI:

·         Moderate involvement of peristriate, then striate cortex

·         Neuronal loss

·         Glial reaction

·         Amyloid angiopathy

·         Almost invariably accompanies Alzheimer

·         Granulovacuolar degeneration

·         Clear intraneuronal cytoplasmic vacuoles

·         Argyrophilic granule within each one

·         Hirano bodies

·         Elongated, glassy, eosinophilic bodies

·         Actin is major component

 

Immunophenotype:

Marker:

Sensitivity:

Specificity:

Congo red (core of neuritic plaques) 

 

 

(core of neuritic plaques)

 

 

Amyloid precursor protein (APP)

 

 

Silver (Bielchowsky) (neurofibrillary tangles)

 

 

Tau protein (neurofibrillary tangles)

 

 

MAP2 (neurofibrillary tangles)

 

 

Ubiquitin (neurofibrillary tangles)

 

 

 

Molecular features:

·         Familial AD (5-10%):

·         APP gene mutations on chromosome 21

·         Result in increased

·         Presenilin-1 (PS1) mutations

·         Component of gamma-secretase

·         Presenilin-2 (PS2) mutations

·         Component of gamma-secretase

·         Epsilon-4 allele of apolipoprotein E (ApoE)

·         Presence of this allele increases risk and lowers age of onset

 

Other features:

·         EM

·         Neurofibrillary tangles:

·         Paired helical filaments

·         Some straight filaments

·         Number of neurofibrillary tangles correlates better with degree of dementia than number of neuritic plaques

·         Transentorhinal stage:

·         Preclinical

·         Isocortical stage:

·         Fully developed AD

 

References:

·         Kumar V, Fausto N, Abbas A. Robbins & Cotran Pathologic Basis of Disease, Seventh Edition. 7th ed. Saunders; 2004.

·         Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239-59.